Helios

Orion Group Partners with Leading Plumbing Service Provider, L.A. Hydro-Jet & Rooter Service

Retrieved on: 
Monday, April 1, 2024

Orion Group (“Orion”), a commercial facility services business, announced today that it has partnered with L.A. Hydro-Jet & Rooter Service (“L.A.

Key Points: 
  • Orion Group (“Orion”), a commercial facility services business, announced today that it has partnered with L.A. Hydro-Jet & Rooter Service (“L.A.
  • Hydro-Jet”).
  • L.A. Hydro-Jet is a leading plumbing business offering drain cleaning, jetting, and sewer repair solutions to commercial facilities throughout Southern California.
  • L.A. Hydro-Jet joins Orion’s national light mechanical service provider, Helios Service Partners, further expanding the business’ service breadth and geographic reach.

White (Natural) Hydrogen Research Report 2024 Featuring Industry Leaders - Helios, Natural Hydrogen Energy, Koloma, Hydroma, H2Au, La Francaise de l Energie SA, Gold Hydrogen, and HyTerra - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 28, 2024

The "White (Natural) Hydrogen Market: Focus on Exploration, Identified Deposits, and Future Scenarios" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "White (Natural) Hydrogen Market: Focus on Exploration, Identified Deposits, and Future Scenarios" report has been added to ResearchAndMarkets.com's offering.
  • This form of hydrogen, which is found in abundance within the Earth's crust, offers an inexhaustible and clean energy source.
  • The key players operating in the white hydrogen market include Helios, Natural Hydrogen Energy LLC, Koloma, Hydroma Inc., H2Au, La Francaise de l Energie SA, Gold Hydrogen Limited, and HyTerra, among others.
  • Competitive Strategy: The key players in the white hydrogen market analyzed and profiled in the study include white hydrogen exploration and extraction companies and upstream service providers.

Supernal Appoints David McBride Chief Technology Officer

Retrieved on: 
Monday, March 25, 2024

IRVINE, Calif., March 25, 2024 /PRNewswire/ -- Supernal LLC – Hyundai Motor Group's Advanced Air Mobility (AAM) company – today announced the appointment of David McBride as Chief Technology Officer (CTO). McBride will lead Supernal's technology strategy and vehicle development, reporting to CEO, Jaiwon Shin.

Key Points: 
  • IRVINE, Calif., March 25, 2024 /PRNewswire/ -- Supernal LLC – Hyundai Motor Group's Advanced Air Mobility (AAM) company – today announced the appointment of David McBride as Chief Technology Officer (CTO).
  • McBride will lead Supernal's technology strategy and vehicle development, reporting to CEO, Jaiwon Shin.
  • McBride brings more than 40 years of experience in developing groundbreaking aerospace technology, complex program management and organizational leadership to Supernal's Engineering and Technology Division (ETD).
  • "I am honored to join Supernal to help certify and commercialize an aircraft that our team has been working toward for the past several years," said McBride.

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Retrieved on: 
Monday, March 4, 2024

NEWTOWN, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has assigned Healthcare Common Procedure Coding System (“HCPCS”) Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece. The new HCPCS codes will be effective April 1, 2024.

Key Points: 
  • The new HCPCS codes will be effective April 1, 2024.
  • “PoNS Therapy® is life-changing for people who suffer gait impairment due to MS and we’re pleased that CMS understood the benefits of this innovative treatment by establishing HCPCS codes for both the PoNS mouthpiece and controller.
  • This marks a critical reimbursement and access milestone and provides Helius the ability to begin negotiating reimbursement with third-party payers using these unique HCPCS codes.
  • In Canada, PoNS is authorized to treat balance impairment due to MS, stroke and mild-to-moderate traumatic brain injury.

General John W. Raymond Joins Board of Impulse Space; Company Recently Selected for Two SBIR Awards by SpaceWERX

Retrieved on: 
Wednesday, February 21, 2024

Impulse Space , a leader of in-space transportation services, has recently welcomed General John W. “Jay” Raymond to its board of directors, bringing decades of experience in government space operations to the Impulse team.

Key Points: 
  • Impulse Space , a leader of in-space transportation services, has recently welcomed General John W. “Jay” Raymond to its board of directors, bringing decades of experience in government space operations to the Impulse team.
  • As a board member, General Raymond will support and advise the Impulse team in its work with government partners and customers.
  • “I am honored to join the Impulse Space team,” said General Raymond.
  • With a vision to enable in-space transportation throughout the solar system, Impulse Space is poised to serve customers across industries.

Orion Group Partners with Leading Beverage Equipment Service Provider, Beverage Equipment Repair Company

Retrieved on: 
Friday, February 9, 2024

Orion Group (“Orion”), a commercial facility services business, announced today that it has partnered with Beverage Equipment Repair Company (“BERCO”).

Key Points: 
  • Orion Group (“Orion”), a commercial facility services business, announced today that it has partnered with Beverage Equipment Repair Company (“BERCO”).
  • BERCO joins Orion’s national light mechanical network, Helios Service Partners, as its sixth partnership, expanding the business’ service capabilities to encompass commercial kitchen equipment.
  • View the full release here: https://www.businesswire.com/news/home/20240209994555/en/
    As a leading service provider with commercial customers throughout Florida, BERCO specializes in food service and beverage equipment repair and installation.
  • Headquartered in Fort Myers, Florida, BERCO is dedicated to providing exceptional customer service and prompt response times to support all beverage equipment service needs.

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Retrieved on: 
Tuesday, February 6, 2024

NEWTOWN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today that it has concluded its interaction with the U.S. Food and Drug Administration (“FDA”) on optimizing the development plan for its stroke program which aims to evaluate the effects of cranial-nerve non-invasive neuromodulation (“CN-NINM”) delivered using PoNS Therapy® on gait and dynamic balance in chronic stroke survivors. Helius’ registrational program includes two controlled studies. The clinical program will leverage a randomized, controlled, double blinded investigator-initiated trial (“IIT”), led by Dr. Steven Kautz at the Medical University of South Carolina (“MUSC”) and a Company-sponsored study to enroll approximately 100 subjects. Dr. Kautz’s IIT began enrollment of 60 participants in September 2023 with the collaboration of Dr. Mark Bowden at Brooks Rehabilitation as a second site.

Key Points: 
  • “Vetting the registrational program and design of our clinical studies with the FDA is an important milestone for Helius and meeting the agency’s expectations will give us the most efficient path to delivering PoNS Therapy to stroke patients,” said Dr. Antonella Favit-Van Pelt, Helius’ Chief Medical Officer.
  • Across all stroke patients in the database, 69.2% of patients experienced at least a 5-point FGA improvement, which is larger than the 4.2-point minimal detectable change usually seen in stroke patients.
  • “One of our chief objectives is to optimize access to PoNS Therapy for stroke patients suffering from gait and balance deficit in North America.
  • PoNS received breakthrough designations in both multiple sclerosis and stroke in the United States, potentially benefiting, with a new indication, an estimated 90% of stroke patients who are covered by Medicare.

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Retrieved on: 
Thursday, January 11, 2024

NEWTOWN, Pa., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the expansion of the registrational program with the addition of Brooks Rehabilitation Hospital (“Brooks Rehabilitation”). The program, structured on the basis of encouraging results from an early trial as well as real-world evidence from Canada, where PoNS is already authorized for treatment of stroke, focuses on establishing the effects of cranial-nerve non-invasive neuromodulation (“CN-NINM”), delivered using PoNS Therapy™, on gait and dynamic balance in chronic stroke survivors. Brooks Rehabilitation will participate as an adjunct site, under the direction of Dr. Mark Bowden, PT, PhD, Vice President of Clinical Integration and Research, to the ongoing investigator-initiated, placebo-controlled study in stroke, led by Dr. Steven Kautz at the Medical University of South Carolina (“MUSC”). Dr. Bowden will also take part in additional clinical activities that, when combined with the randomized controlled study, aim to bring the total number of subjects enrolled in the clinical program to approximately 100.

Key Points: 
  • Dr. Bowden will also take part in additional clinical activities that, when combined with the randomized controlled study, aim to bring the total number of subjects enrolled in the clinical program to approximately 100.
  • “The participation of Brooks Rehabilitation marks an important step in the implementation of our clinical program under breakthrough designation for stroke.
  • Dr. Bowden, with his longstanding leadership and contribution to the field of neurorehabilitation for stroke, brings the expertise needed to execute our registrational program.
  • Starting in January 2024, Dr. Bowden anticipates enrolling approximately 40 participants to the development program at Brooks Rehabilitation and expects full enrollment by the end of the year.

Acer Refreshes Predator Helios Gaming Laptops with Intel Core 14th Gen Processors and NVIDIA GeForce RTX 40 Series Laptop GPUs

Retrieved on: 
Monday, January 8, 2024

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- Acer unleashes a series of powerhouse gaming laptops, headlined by the refreshed models of the Predator Helios 18 and Predator Helios 16. Acer also announced the new Predator Helios Neo 18 gaming laptop and major updates to the Predator Helios Neo 16, all outfitted with the latest Intel® Core™ 14th gen processors and NVIDIA® GeForce RTX™ 40 Series Laptop GPUs with DLSS 3.5 technology and NVIDIA Advanced Optimus. NVIDIA RTX Laptop GPUs are packed with specialized AI Tensor Cores enabling unmatched AI performance and accelerations in creative apps, ultra-efficient productivity, blistering fast gaming, and more. The Predator laptops feature Microsoft's Copilot in Windows 11 and a dedicated Copilot key for quick access to AI-powered task assistance. They also come with one month of Xbox Game Pass Ultimate, giving gamers access to hundreds of high-quality PC games.

Key Points: 
  • Acer also announced the new Predator Helios Neo 18 gaming laptop and major updates to the Predator Helios Neo 16, all outfitted with the latest Intel® Core™ 14th gen processors and NVIDIA® GeForce RTX™ 40 Series Laptop GPUs with DLSS 3.5 technology and NVIDIA Advanced Optimus.
  • NVIDIA RTX Laptop GPUs are packed with specialized AI Tensor Cores enabling unmatched AI performance and accelerations in creative apps, ultra-efficient productivity, blistering fast gaming, and more.
  • "The new Acer Predator Helios is a beautiful laptop that truly unleashes the performance of our new Intel Core (14th Gen) HX-Series processors," says Roger Chandler, VP & GM Enthusiast PC & Workstation at Intel.
  • The Predator Helios 16 and Predator Helios 18 laptops also come with the latest sensory technology features.

UVeye Partners with Hypertec to Mass-Produce AI Vehicle Inspection Systems in North America

Retrieved on: 
Monday, December 4, 2023

Industry giants such as General Motors Co., Volvo Cars, and renowned used car retailer CarMax, are all part of this dynamic landscape.

Key Points: 
  • Industry giants such as General Motors Co., Volvo Cars, and renowned used car retailer CarMax, are all part of this dynamic landscape.
  • A joint team of UVeye and Hypertec engineering and technical experts will be formed to ensure seamless installation, servicing, and customer training for the new systems.
  • “Our drive-through inspection systems have consistently demonstrated exceptional performance, detecting 96 percent of existing vehicle problems within seconds, in contrast to less than 25 percent accuracy for traditional manual checks.
  • Simon Ahdoot, President of Hardware Technology Solutions at Hypertec, highlighted the perfect synergy in this partnership of innovators creating value."